The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and womenJ. A. Kanis, Noriko Yoshimura, Chris De Laet et al.|Osteoporosis International|2007Cited by 1.2k
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.J.J. Body, R.D. Rubens, Reiner Bartl et al.|Journal of Clinical Oncology|1998Cited by 366